Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Rev. bras. hipertens ; 30(2): 53-58, jun. 2023. ilus
Article in Portuguese | LILACS | ID: biblio-1517375

ABSTRACT

Evidências demonstram que não só a elevação da pressão arterial, mas também o aumento da variabilidade da pressão arterial (VPA) pode contribuir para a piora no dano renal e redução da sobrevida em portadores doença renal crônica. Este artigo tem como objetivo revisar o impacto da disfunção autonômica cardiovascular (hiperatividade simpática, prejuízo nasensibilidade dos barorreceptores e/ou aumento da VPA) e sua associação com inflamação e estresse oxidativo no desenvolvimento e progressão do dano renal (AU).


Evidence shows that not only the increase in blood pressure, but also the increase in blood pressure variability (BPV) can contribute to worsening kidney damage and reduced survival in patients with chronic kidney disease. This article aims to review the impact of cardiovascular autonomic dysfunction (sympathetic hyperactivity, impaired baroreflex sensitivity and/or increased BPV) and its association with inflammation and oxidative stress on the development and progression of renal damage (AU).


Subject(s)
Humans , Cardiovascular Diseases , Kidney/pathology
2.
Einstein (Säo Paulo) ; 12(4): 413-419, Oct-Dec/2014. tab, graf
Article in English | LILACS | ID: lil-732452

ABSTRACT

Objective To evaluate the effect of maternal diabetes on the blood pressure and kidney function of female offspring, as well as if such changes exacerbate during pregnancy. Methods Diabetes mellitus was induced in female rats with the administration of streptozotocin in a single dose, one week before mating. During pregnancy, blood pressure was measured through plethysmography. On the 20th day of pregnancy, the animals were placed for 24 hours in metabolic cages to obtain urine samples. After the animals were removed from the cages, blood samples were withdrawn. One month after pregnancy, new blood and urine sample were collected. Kidney function was evaluated through proteinuria, plasma urea, plasma creatinine, creatinine excretion rate, urinary flow, and creatinine clearance. Results The female offspring from diabetic mothers showed an increase in blood pressure, and a decrease in glomerular filtration rate in relation to the control group. Conclusion Hyperglycemia during pregnancy was capable of causing an increase in blood pressure and kidney dysfunction in the female offspring. .


Objetivo Avaliar o efeito do diabetes materno sobre a pressão arterial e a função renal da prole feminina, bem como verificar se as alterações observadas se exacerbam durante a prenhez. Métodos O diabetes mellitus foi induzido em ratas com a administração de estreptozocina em dose única, uma semana antes do cruzamento. Durante a prenhez, foram feitas medidas da pressão arterial por pletismografia. No 20o dia da prenhez, os animais foram colocados durante 24 horas em gaiolas metabólicas para obtenção de amostras de urina. Após a retirada dos animais das gaiolas, foram obtidas amostras de sangue. Um mês após a prenhez, foram obtidas novas amostras de sangue e urina para as determinações. A função renal foi avaliada por meio de proteinúria, ureia plasmática, creatinina plasmática, carga excretada de creatinina, fluxo urinário e clearance de creatinina. Resultados As fêmeas da prole de mães diabéticas apresentaram elevação da pressão arterial e redução do ritmo de filtração glomerular em relação ao grupo controle. Conclusão A hiperglicemia durante a gestação foi capaz de causar elevação da pressão arterial e disfunção renal na prole de sexo feminino. .


Subject(s)
Animals , Female , Pregnancy , Diabetes Mellitus, Experimental/complications , Diabetic Nephropathies/etiology , Hypertension/etiology , Pregnancy in Diabetics , Prenatal Exposure Delayed Effects/etiology , Creatinine/blood , Disease Models, Animal , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/metabolism , Diabetic Nephropathies/physiopathology , Gestational Age , Glomerular Filtration Rate , Hyperglycemia/complications , Hypertension/physiopathology , Kidney/physiopathology , Pregnancy in Diabetics/metabolism , Prenatal Exposure Delayed Effects/physiopathology , Proteinuria/urine , Rats, Wistar , Reference Values , Streptozocin , Time Factors , Urea/blood
3.
Clinics ; 68(6): 858-864, jun. 2013. tab, graf
Article in English | LILACS | ID: lil-676929

ABSTRACT

OBJECTIVES: Myeloid-derived suppressor cells contribute to the immunosuppressive microenvironment during tumor development and limit the efficacy of cancer immunotherapy. Identifying myeloid-derived suppressor cells and associated factors is the first step in creating strategies to reverse the suppressive effects of these cells on the immune system. METHODS: To induce lung cancer, we administered 2 doses of urethane to BALB/c mice and observed these animals for 120 days. After this period, we evaluated the percentage of myeloid-derived suppressor cells in the blood, lung and bone marrow. The expression of alpha-smooth muscle actin, transforming growth factor-β, Toll-like receptor 2, Toll-like receptor 4, and interleukin-6 was also determined in the lung tissue. RESULTS: Myeloid-derived suppressor cells were increased in all evaluated tissues after lung cancer development in association with increased Toll-like receptor 4 expression and decreased interleukin-6 expression in the lung. We observed alpha-smooth muscle actin and transforming growth factor-β expression in lung nodules. CONCLUSIONS: We believe that the early diagnosis of cancer through determining the blood levels of myeloid-derived suppressor cells followed by the depletion of these cells should be further investigated as a possible approach for cancer treatment. .


Subject(s)
Animals , Male , Mice , Lung Neoplasms/pathology , Myeloid Cells/pathology , Actins/metabolism , Blotting, Western , Carcinogens , Flow Cytometry , Immunohistochemistry , /metabolism , Lung Neoplasms/chemically induced , Lung Neoplasms/immunology , Lung/drug effects , Lung/pathology , Mice, Inbred BALB C , Myeloid Cells/immunology , Time Factors , /metabolism , Urethane
4.
Braz. j. pharm. sci ; 48(2): 291-298, Apr.-June 2012. ilus, graf, tab
Article in English | LILACS | ID: lil-643022

ABSTRACT

This study investigated the beneficial effects of D-α-tocopherol supplementation in protecting against the renal morphological and functional changes caused by hypertension. Spontaneously hypertensive (SHR) and normotensive control (WKY) rats received D-α-tocopherol (80 mg/kg by gavage) or vehicle (mineral oil) every other day for 60 days, from the age of 2 months. After this treatment period, all animals were assessed for renal morphological and functional parameters. The glomerular hypertrophy, increased interlobular wall thickness and enlarged renal vascular resistance found in SHR were reduced by D-α-tocopherol treatment. Sodium and volume retention observed in SHR were also decreased by D-α-tocopherol treatment. Moreover, D-α-tocopherol supplementation significantly reduced arterial pressure in SHR but not in WKY. D-α-tocopherol also reduced the excretion of thiobarbituric acid-reactive substances (TBARS), a marker of oxidative stress, in SHR. These results suggest that D-α-tocopherol supplementation can reduce kidney damage induced by hypertension.


O presente estudo avaliou os efeitos benéficos da suplementação com D-α-tocopherol sobre as alterações morfológicas e funcionais renais causadas pela hipertensão arterial. A partir de dois meses de idade, ratos espontaneamente hipertensos (SHR) e controles normotensos (WKY) receberam D-α-tocoferol (80 mg/kg por gavagem) ou veículo (óleo mineral) em dias alternados, por 60 dias. Após este período foram avaliados os parâmetros morfofuncionais dos rins. Os animais SHR apresentaram: hipertrofia glomerular, aumento da espessura da parede das arterias interlobulares e elevação da resistência vascular renal. Estas alterações foram menores nos animais SHR suplementados com D-α-tocoferol. A retenção de sódio e de volume encontrada nos SHR também foi reduzida com o tratamento com D-α-tocoferol. Além disso, a suplementação com D-α-tocoferol reduziu significativamente a pressão arterial em SHR, mas não em WKY. Houve, também, redução da excreção de ácido tiobarbitúrico (TBARS), um marcador de estresse oxidativo, nos animais SHR tratados com D-α-tocoferol. Os resultados sugerem que suplementação com D-α-tocoferol é capaz de reduzir importantes alterações renais causadas pela hipertensão arterial.


Subject(s)
Rats , Rats/classification , alpha-Tocopherol/analysis , Acute Kidney Injury/classification , Hypertension/classification
SELECTION OF CITATIONS
SEARCH DETAIL